Diagnosis and treatment of pulmonary hypertension in infancy

Robin H Steinhorn

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Normal pulmonary vascular development in infancy requires maintenance of low pulmonary vascular resistance after birth, and is necessary for normal lung function and growth. The developing lung is subject to multiple genetic, pathological and/or environmental influences that can adversely affect lung adaptation, development, and growth, leading to pulmonary hypertension. New classifications of pulmonary hypertension are beginning to account for these diverse phenotypes, and or pulmonary hypertension in infants due to PPHN, congenital diaphragmatic hernia, and bronchopulmonary dysplasia (BPD). The most effective pharmacotherapeutic strategies for infants with PPHN are directed at selective reduction of PVR, and take advantage of a rapidly advancing understanding of the altered signaling pathways in the remodeled vasculature.

Original languageEnglish (US)
Pages (from-to)865-874
Number of pages10
JournalEarly Human Development
Volume89
Issue number11
DOIs
StatePublished - Nov 2013

Fingerprint

Pulmonary Hypertension
Lung
Bronchopulmonary Dysplasia
Therapeutics
Growth and Development
Vascular Resistance
Blood Vessels
Maintenance
Parturition
Phenotype
Growth

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Diagnosis and treatment of pulmonary hypertension in infancy. / Steinhorn, Robin H.

In: Early Human Development, Vol. 89, No. 11, 11.2013, p. 865-874.

Research output: Contribution to journalArticle

Steinhorn, Robin H. / Diagnosis and treatment of pulmonary hypertension in infancy. In: Early Human Development. 2013 ; Vol. 89, No. 11. pp. 865-874.
@article{62752cd0cbe5485bb9bbfc315c96194a,
title = "Diagnosis and treatment of pulmonary hypertension in infancy",
abstract = "Normal pulmonary vascular development in infancy requires maintenance of low pulmonary vascular resistance after birth, and is necessary for normal lung function and growth. The developing lung is subject to multiple genetic, pathological and/or environmental influences that can adversely affect lung adaptation, development, and growth, leading to pulmonary hypertension. New classifications of pulmonary hypertension are beginning to account for these diverse phenotypes, and or pulmonary hypertension in infants due to PPHN, congenital diaphragmatic hernia, and bronchopulmonary dysplasia (BPD). The most effective pharmacotherapeutic strategies for infants with PPHN are directed at selective reduction of PVR, and take advantage of a rapidly advancing understanding of the altered signaling pathways in the remodeled vasculature.",
author = "Steinhorn, {Robin H}",
year = "2013",
month = "11",
doi = "10.1016/j.earlhumdev.2013.09.012",
language = "English (US)",
volume = "89",
pages = "865--874",
journal = "Early Human Development",
issn = "0378-3782",
publisher = "Elsevier Ireland Ltd",
number = "11",

}

TY - JOUR

T1 - Diagnosis and treatment of pulmonary hypertension in infancy

AU - Steinhorn, Robin H

PY - 2013/11

Y1 - 2013/11

N2 - Normal pulmonary vascular development in infancy requires maintenance of low pulmonary vascular resistance after birth, and is necessary for normal lung function and growth. The developing lung is subject to multiple genetic, pathological and/or environmental influences that can adversely affect lung adaptation, development, and growth, leading to pulmonary hypertension. New classifications of pulmonary hypertension are beginning to account for these diverse phenotypes, and or pulmonary hypertension in infants due to PPHN, congenital diaphragmatic hernia, and bronchopulmonary dysplasia (BPD). The most effective pharmacotherapeutic strategies for infants with PPHN are directed at selective reduction of PVR, and take advantage of a rapidly advancing understanding of the altered signaling pathways in the remodeled vasculature.

AB - Normal pulmonary vascular development in infancy requires maintenance of low pulmonary vascular resistance after birth, and is necessary for normal lung function and growth. The developing lung is subject to multiple genetic, pathological and/or environmental influences that can adversely affect lung adaptation, development, and growth, leading to pulmonary hypertension. New classifications of pulmonary hypertension are beginning to account for these diverse phenotypes, and or pulmonary hypertension in infants due to PPHN, congenital diaphragmatic hernia, and bronchopulmonary dysplasia (BPD). The most effective pharmacotherapeutic strategies for infants with PPHN are directed at selective reduction of PVR, and take advantage of a rapidly advancing understanding of the altered signaling pathways in the remodeled vasculature.

UR - http://www.scopus.com/inward/record.url?scp=84886287187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886287187&partnerID=8YFLogxK

U2 - 10.1016/j.earlhumdev.2013.09.012

DO - 10.1016/j.earlhumdev.2013.09.012

M3 - Article

C2 - 24083892

AN - SCOPUS:84886287187

VL - 89

SP - 865

EP - 874

JO - Early Human Development

JF - Early Human Development

SN - 0378-3782

IS - 11

ER -